Drug name - Rasuvo

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8664231 MEDEXUS Concentrated methotrexate solutions Jun, 2029

(6 years from now)

Drugs and Companies using METHOTREXATE ingredient

Treatment: Subcutaneous injection of methotrexate

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
7.5MG/0.15ML (7.5MG/0.15ML) SOLUTION;SUBCUTANEOUS Prescription
10MG/0.20ML (10MG/0.20ML) SOLUTION;SUBCUTANEOUS Prescription
12.5MG/0.25ML (12.5MG/0.25ML) SOLUTION;SUBCUTANEOUS Prescription
15MG/0.30ML (15MG/0.30ML) SOLUTION;SUBCUTANEOUS Prescription
17.5MG/0.35ML (17.5MG/0.35ML) SOLUTION;SUBCUTANEOUS Prescription
20MG/0.4ML (20MG/0.4ML) SOLUTION;SUBCUTANEOUS Prescription
22.5MG/0.45ML (22.5MG/0.45ML) SOLUTION;SUBCUTANEOUS Prescription
25MG/0.5ML (25MG/0.5ML) SOLUTION;SUBCUTANEOUS Prescription
27.5MG/0.55ML (27.5MG/0.55ML) SOLUTION;SUBCUTANEOUS Discontinued
30MG/0.6ML (30MG/0.6ML) SOLUTION;SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.